A patient is eligible for an experimental treatment if the patient has:
(1) evaluated other treatment options currently approved by the United States food and drug administration;
(2) received a recommendation from the patient's treating health care provider for an experimental treatment;
(3) given informed consent for the use of the experimental treatment; and
(4) received documentation from the treating health care provider that the patient meets the requirements of this section.